Fully-automated deep learning-powered system for DCE-MRI analysis of brain tumors
Pith reviewed 2026-05-24 19:12 UTC · model grok-4.3
The pith
A deep learning system fully automates DCE-MRI brain tumor analysis with state-of-the-art accuracy in under three minutes on one GPU.
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
Core claim
Our deep learning-powered technique does not require any user interaction, it yields reproducible results, and it is rigorously validated against benchmark (BraTS'17 for tumor segmentation, and a test dataset released by the Quantitative Imaging Biomarkers Alliance for the contrast-concentration fitting) and clinical (44 low-grade glioma patients) data. Also, we introduce a cubic model of the vascular input function used for pharmacokinetic modeling which significantly decreases the fitting error when compared with the state of the art, alongside a real-time algorithm for determination of the vascular input region. An extensive experimental study, backed up with statistical tests, showed our
What carries the argument
End-to-end deep learning pipeline that performs tumor segmentation, real-time vascular input region detection, and pharmacokinetic modeling with a cubic vascular input function.
If this is right
- Quantitative contrast-concentration fitting and tumor segmentation become available without manual contouring or parameter tuning.
- An entire DCE-MRI study finishes in less than three minutes on one GPU instead of the longer times required by manual methods.
- The cubic vascular input function model produces lower fitting error than earlier models on the same data.
- Results stay consistent across public benchmarks and the clinical low-grade glioma cohort.
Where Pith is reading between the lines
- The same pipeline could be retrained on data from other tumor grades or body sites to test whether automation generalizes.
- Embedding the system into scanner consoles might allow immediate biomarker maps during the scan session.
- Combining the output maps with diffusion or perfusion sequences could tighten diagnostic criteria for tumor grading.
Load-bearing premise
Models tuned on BraTS'17 and the QIBA test set will keep the same segmentation accuracy and fitting performance on the separate set of 44 low-grade glioma patients.
What would settle it
Performance on a new independent collection of DCE-MRI studies from different scanners or patient groups falls below the reported segmentation and fitting scores.
Figures
read the original abstract
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) plays an important role in diagnosis and grading of brain tumor. Although manual DCE biomarker extraction algorithms boost the diagnostic yield of DCE-MRI by providing quantitative information on tumor prognosis and prediction, they are time-consuming and prone to human error. In this paper, we propose a fully-automated, end-to-end system for DCE-MRI analysis of brain tumors. Our deep learning-powered technique does not require any user interaction, it yields reproducible results, and it is rigorously validated against benchmark (BraTS'17 for tumor segmentation, and a test dataset released by the Quantitative Imaging Biomarkers Alliance for the contrast-concentration fitting) and clinical (44 low-grade glioma patients) data. Also, we introduce a cubic model of the vascular input function used for pharmacokinetic modeling which significantly decreases the fitting error when compared with the state of the art, alongside a real-time algorithm for determination of the vascular input region. An extensive experimental study, backed up with statistical tests, showed that our system delivers state-of-the-art results (in terms of segmentation accuracy and contrast-concentration fitting) while requiring less than 3 minutes to process an entire input DCE-MRI study using a single GPU.
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The manuscript describes a fully-automated end-to-end deep-learning system for DCE-MRI analysis of brain tumors that performs tumor segmentation, real-time vascular input function (VIF) region detection, and pharmacokinetic modeling with a newly introduced cubic VIF model. It reports validation against BraTS'17 (segmentation), the QIBA phantom test set (contrast-concentration fitting), and an independent clinical cohort of 44 low-grade glioma patients, claiming state-of-the-art accuracy, reduced fitting error relative to prior VIF models, and end-to-end runtime under 3 minutes on a single GPU, with supporting statistical tests.
Significance. If the reported performance generalizes, the work would deliver a practical, reproducible tool that removes manual steps from quantitative DCE-MRI biomarker extraction, directly addressing time and variability barriers in clinical tumor grading and prognosis. The cubic VIF model, if shown to be robust rather than over-parameterized, would constitute a concrete methodological advance in pharmacokinetic fitting.
major comments (2)
- [Abstract / clinical-validation section] Abstract and clinical-validation section: the headline SOTA claim on the 44-patient low-grade glioma cohort rests on the assumption that BraTS'17-trained segmentation and QIBA-tuned fitting models transfer without measurable domain shift. The manuscript must supply explicit numerical metrics (Dice, Hausdorff, fitting RMSE or R²) for the clinical cases side-by-side with the benchmark numbers, together with any domain-adaptation steps or statistical tests for distribution shift; without these, the independent-validation assertion cannot be evaluated.
- [VIF-model section] VIF-model section: the cubic model is introduced as an invented functional form that 'significantly decreases the fitting error.' The manuscript must state the exact equation (including the three free coefficients), compare it to the standard biexponential or other QIBA reference models on identical data, and demonstrate that the error reduction is not an artifact of the added degrees of freedom; otherwise the improvement claim is not load-bearing.
minor comments (2)
- Clarify whether the 44 clinical cases were used only for final testing or whether any hyper-parameter tuning occurred on them; if the latter, the independence of the validation set is compromised.
- Provide error bars or confidence intervals on all reported metrics (Dice, fitting error, runtime) and state the exact statistical tests used for the SOTA comparisons.
Simulated Author's Rebuttal
We thank the referee for the constructive and detailed comments. We address each major point below and will revise the manuscript to strengthen the presentation of results and methods.
read point-by-point responses
-
Referee: [Abstract / clinical-validation section] Abstract and clinical-validation section: the headline SOTA claim on the 44-patient low-grade glioma cohort rests on the assumption that BraTS'17-trained segmentation and QIBA-tuned fitting models transfer without measurable domain shift. The manuscript must supply explicit numerical metrics (Dice, Hausdorff, fitting RMSE or R²) for the clinical cases side-by-side with the benchmark numbers, together with any domain-adaptation steps or statistical tests for distribution shift; without these, the independent-validation assertion cannot be evaluated.
Authors: We agree that a direct side-by-side comparison would make the transfer performance clearer. The manuscript already reports segmentation and fitting metrics on the 44 clinical cases, but we will add an explicit comparative table in the clinical-validation section showing Dice, Hausdorff, RMSE and R² values for both the BraTS/QIBA benchmarks and the clinical cohort. We will also include statistical tests (e.g., Kolmogorov-Smirnov or Mann-Whitney) for distribution shift between the benchmark and clinical data distributions. No domain-adaptation steps were applied; the models were used in a direct transfer setting to assess generalization. revision: yes
-
Referee: [VIF-model section] VIF-model section: the cubic model is introduced as an invented functional form that 'significantly decreases the fitting error.' The manuscript must state the exact equation (including the three free coefficients), compare it to the standard biexponential or other QIBA reference models on identical data, and demonstrate that the error reduction is not an artifact of the added degrees of freedom; otherwise the improvement claim is not load-bearing.
Authors: We will state the exact cubic VIF equation, including the three free coefficients, in the revised VIF-model section. Direct numerical comparisons of fitting error (RMSE) between the cubic model and the standard biexponential (and other QIBA reference) models on the identical QIBA phantom data will be added. To address the degrees-of-freedom concern, we will include an AIC-based model-selection analysis demonstrating that the error reduction is not explained by the additional parameters alone. revision: yes
Circularity Check
No circularity; claims rest on external benchmarks and separate clinical cohort
full rationale
The paper's core claims concern segmentation accuracy on BraTS'17, contrast-concentration fitting on the QIBA test set, and performance on a distinct 44-patient low-grade glioma clinical cohort, with no equations, fitted parameters, or self-citations presented as load-bearing derivations. The introduced cubic vascular input function model is described as reducing fitting error relative to prior art without reducing to a self-referential fit. All reported results are positioned as comparisons against independent public benchmarks and a held-out clinical set, satisfying the criteria for a self-contained derivation with no reductions by construction.
Axiom & Free-Parameter Ledger
free parameters (1)
- cubic VIF model coefficients
axioms (1)
- domain assumption Deep learning models trained on BraTS'17 generalize sufficiently to produce state-of-the-art tumor segmentation on the authors' clinical DCE-MRI data.
invented entities (1)
-
cubic model of the vascular input function
no independent evidence
Reference graph
Works this paper leans on
-
[1]
T. Abe, et al., Diagnosis of brain tumors using dynamic contrast-enhanced perfusion imaging with short acquisition time, Springer 4 (1) (2015) 88
work page 2015
-
[2]
P. Aljabar, et al., Multi-atlas based segmentation of brain images: Atlas selection and its effect on accuracy, NeuroImage 46 (3) (2009) 726 – 738
work page 2009
-
[3]
S. Bakas, et al., Advancing the cancer genome atlas glioma MRI collections with expert segmentation labels and radiomic features, Scientific data 4 (2017) 1–13
work page 2017
- [4]
-
[5]
S. Bauer, et al., Atlas-based segmentation of brain tumor images using a Markov Random Field-based tumor growth model and non-rigid registra- tion, in: Proc. IEEE EMBC, 2010, pp. 4080–4083
work page 2010
-
[6]
A. Bjrnerud, K. E. Emblem, A fully automated method for quantitative cerebral hemodynamic analysis using dscmri, Journal of Cerebral Blood Flow & Metabolism 30 (5) (2010) 1066–1078
work page 2010
-
[7]
A. Chander, A. Chatterjee, P. Siarry, A new social and momentum com- ponent adaptive PSO algorithm for image segmentation, Expert Systems with Applications 38 (5) (2011) 4998 – 5004
work page 2011
-
[8]
S.-L. Chao, T. Metens, M. Lemort, Tumourmetrics: a comprehensive clin- ical solution for the standardization of dce-mri analysis in research and routine use, J. QIMS 7 (5)
- [9]
-
[10]
Dozat, Incorporating Nesterov Momentum into Adam, in: Proc
T. Dozat, Incorporating Nesterov Momentum into Adam, in: Proc. Work- shop track - ICLR 2016, 2015, pp. 1–6. 27
work page 2016
-
[11]
X. Fan, et al., A novel unsupervised segmentation method for MR brain images based on fuzzy methods, in: Proc. CVBIA, Springer, Berlin, 2005, pp. 160–169
work page 2005
-
[12]
E. Geremia, et al., Spatial decision forests for MS lesion segmentation in multi-channel magnetic resonance images, NeuroImage 57 (2) (2011) 378 – 390
work page 2011
-
[13]
M. Ghafoorian, et al., Location sensitive deep convolutional neu- ral networks for segmentation of white matter hyperintensities, CoRR abs/1610.04834
work page internal anchor Pith review Pith/arXiv arXiv
-
[14]
M. Ghafoorian, et al., Transfer learning for domain adaptation in MRI: application in brain lesion segmentation, in: Proc. MICCAI, 2017, pp. 516–524
work page 2017
-
[15]
S. Ji, B. Wei, Z. Yu, G. Yang, Y. Yin, A new multistage medical segmen- tation method based on superpixel and fuzzy clustering, Comp. and Math. Meth. in Med. 2014 (2014) 747549:1–747549:13
work page 2014
-
[16]
K. Kamnitsas, et al., Ensembles of multiple models and architectures for robust brain tumour segmentation, in: Brainlesion: Glioma, Multiple Scle- rosis, Stroke and Traumatic Brain Inj., Springer, 2018, pp. 450–462
work page 2018
-
[17]
P. Korfiatis, T. L. Kline, B. J. Erickson, Automated segmentation of hyper- intense regions in FLAIR MRI using deep learning, Tomography: a journal for imaging research 2 (4) (2016) 334340
work page 2016
-
[18]
A. Ladgham, G. Torkhani, A. Sakly, A. Mtibaa, Modified support vector machines for MR brain images recognition, in: Proc. CoDIT, 2013, pp. 032–035
work page 2013
-
[19]
P. Liskowski, K. Krawiec, Segmenting retinal blood vessels with deep neural networks, IEEE Transactions on Medical Imaging 35 (11) (2016) 2369– 2380. 28
work page 2016
-
[20]
P. R. Lorenzo, J. Nalepa, Memetic evolution of deep neural networks, in: Proc. GECCO, ACM, 2018, pp. 505–512
work page 2018
-
[21]
P. A. Mei, et al., Analysis of neoplastic lesions in magnetic resonance imag- ing using self-organizing maps, Journal of the Neurological Sciences 359 (1-
-
[22]
B. H. Menze, et al., The multimodal brain tumor image segmentation benchmark (brats), IEEE Transactions on Medical Imaging 34 (10) (2015) 1993–2024
work page 2015
-
[23]
K. A. Miles, B. Ganeshan, M. P. Hayball, CT texture analysis using the filtration-histogram method: what do the measurements mean?, Cancer Imaging 13 (4) (2013) 400–406
work page 2013
-
[24]
P. Moeskops, et al., Automatic segmentation of MR brain images with a convolutional neural network, IEEE Transactions on Medical Imaging 35 (5) (2016) 1252–1261
work page 2016
- [25]
- [26]
-
[27]
M. R. Orton, J. A. d’Arcy, S. Walker-Samuel, D. J. Hawkes, D. Atkinson, D. J. Collins, M. O. Leach, Computationally efficient vascular input func- tion models for quantitative kinetic modelling using DCE-MRI, Physics in Medicine & Biology 53 (5) (2008) 1225
work page 2008
-
[28]
M. T. M. Park, et al., Derivation of high-resolution MRI atlases of the human cerebellum at 3T and segmentation using multiple automatically generated templates, NeuroImage 95 (2014) 217 – 231. 29
work page 2014
-
[29]
N. Passat, et al., Watershed and multimodal data for brain vessel seg- mentation: Application to the superior sagittal sinus, Image and Vision Computing 25 (4) (2007) 512 – 521
work page 2007
- [30]
-
[31]
J. Pipitone, et al., Multi-atlas segmentation of the whole hippocampus and subfields using multiple automatically generated templates, NeuroImage 101 (2014) 494 – 512
work page 2014
-
[32]
R. Port, M. Knopp, G. Brix, Dynamic contrast-enhanced MRI using Gd- DTPA: Interindividual variability of the arterial input function and conse- quences for the assessment of kinetics in tumors, Magn. Res. in Med. 45 (6) (2001) 1030–1038
work page 2001
-
[33]
A. Rajendran, R. Dhanasekaran, Fuzzy clustering and deformable model for tumor segmentation on MRI brain image: A combined approach, Procedia Engineering 30 (2012) 327 – 333
work page 2012
- [34]
-
[35]
R. G. Rodr´ ıguez Colmeiro, C. A. Verrastro, T. Grosges, Multimodal brain tumor segmentation using 3D convolutional networks, in: Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Inj., Springer, 2018, pp. 226–240
work page 2018
-
[36]
U-Net: Convolutional Networks for Biomedical Image Segmentation
O. Ronneberger, P. Fischer, T. Brox, U-Net: Convolutional networks for biomedical image segmentation, CoRR abs/1505.04597. 30
work page internal anchor Pith review Pith/arXiv arXiv
-
[37]
S. Saha, S. Bandyopadhyay, MRI brain image segmentation by fuzzy sym- metry based genetic clustering technique, in: Proc. IEEE CEC, 2007, pp. 4417–4424
work page 2007
-
[38]
V. Simi, J. Joseph, Segmentation of glioblastoma multiforme from MR images - a comprehensive review, The Egyptian Journal of Radiology and Nuclear Medicine 46 (4) (2015) 1105–1110
work page 2015
-
[39]
D. S. Smith, X. Li, L. R. Arlinghaus, T. E. Yankeelov, E. B. Welch, DCEMRI.jl: a fast, validated, open source toolkit for dynamic contrast enhanced MRI analysis, PeerJ 3 (2015) e909
work page 2015
-
[40]
M. Soltaninejad, et al., Automated brain tumour detection and segmen- tation using superpixel-based extremely randomized trees in FLAIR MRI, Int. J. of Comp. Assist. Radiol. and Surgery 12 (2) (2017) 183–203
work page 2017
-
[41]
C. Sun, S. Guo, H. Zhang, J. Li, M. Chen, S. Ma, L. Jin, X. Liu, X. Li, X. Qian, Automatic segmentation of liver tumors from multiphase contrast- enhanced ct images based on fcns, Artificial Intelligence in Medicine 83 (2017) 58 – 66
work page 2017
-
[42]
M. Taherdangkoo, et al., An effective method for segmentation of MR brain images using the ant colony optimization algorithm, Journal of Digital Imaging 26 (6) (2013) 1116–1123
work page 2013
-
[43]
P. S. Tofts, A. G. Kermode, Measurement of the bloodbrain barrier perme- ability and leakage space using dynamic MR imaging, Magn. Res. in Med. 17 (2) (1991) 357–367
work page 1991
- [44]
-
[45]
W. Wu, et al., Brain tumor detection and segmentation in a CRF frame- work with pixel-pairwise affinity and superpixel-level features, Int. J. CARS 9 (2) (2014) 241–253. 31
work page 2014
-
[46]
J. Yin, J. Yang, Q. Guo, Automatic determination of the arterial input function in dynamic susceptibility contrast MRI: comparison of different reproducible clustering algorithms, Neuroradiology 57 (5) (2015) 535–543
work page 2015
-
[47]
X. Zhao, Y. Wu, G. Song, Z. Li, Y. Zhang, Y. Fan, A deep learning model integrating FCNNs and CRFs for brain tumor segmentation, CoRR abs/1702.04528
work page internal anchor Pith review Pith/arXiv arXiv
- [48]
- [49]
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.